SCHEMBL26435357

SCHEMBL26435357

c1ccc2c(c1)ccc1cccc(-c3nc(-c4ccc(-c5ccc6sc7ccccc7c6c5)cc4)nc(-c4ccc5c(c4)sc4ccccc45)n3)c12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
RAB9A P51151 1/20 0.34
ALOX5 P09917 1/20 0.33
PIM3 Q86V86 1/20 0.33
GPR3 P46089 1/20 0.32
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
MCL1 Q07820 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
POLB P06746 1/20 0.31
F9 P00740 1/20 0.31
CYP1A2 P05177 2/20 0.30
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435396 1.00 ALDH1A1 (0.34) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL26435354 0.96 ALDH1A1 (0.36) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL26435332 0.93 S1PR5 (0.35) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL26435376 0.93 PIM3 (0.37) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL26435378 0.92 PIM3 (0.39) ALDH1A1MAPTHPGDSMN1; SMN2ALOX5
SCHEMBL26435331 0.91 F9 (0.37) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL26435375 0.91 ALOX5 (0.36) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL25817919 0.89 F9 (0.34) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL24473202 0.89 F9 (0.36) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL26435388 0.89 PIM3 (0.36) ALDH1A1MAPTHPGDSMN1; SMN2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALDH1A1 1532/4885MAPT 2425/4885HPGD 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.